Journal of Endocrinological Investigation

, Volume 26, Issue 6, pp 570–574 | Cite as

Genetics of thyroid-associated ophthalmopathy: A play in search of a cast of characters


Key words

Thyroid-associated ophthalmopathy Graves’ disease genetics linkage association multifactorial 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Farid N.R., and Balazs C. The genetics of thyroid associated opthalmopathy. Thyroid 1998, 5: 407–409.CrossRefGoogle Scholar
  2. 2.
    Todd J.A. Human genetics. Tackling common disease. Nature 2001, 411: 537–539.PubMedCrossRefGoogle Scholar
  3. 3.
    Podolsky D.K. Inflammatory bowel disease. N. Eng. J. Med. 2002, 347: 417–429.CrossRefGoogle Scholar
  4. 4.
    Burghes A.H.M., Vaessin H.E.F., de la Chapelle A. The land between Menedelian and multifactorial inheritance. Science 2001, 293: 2213–2214.PubMedCrossRefGoogle Scholar
  5. 5.
    Stenzsky V., Kozma L., Balazs C., Rochltiz S., Bear J.C., Farid N.R. The genetics of Graves’ disease: HLA and disease susceptibility J. Clin. Endocrinol. Metab. 1985, 61: 735–740.CrossRefGoogle Scholar
  6. 6.
    Ban Y., Davies T.F., Greenberg D.A., Concepcion E.S., Tomer Y. Potential role of HLA-DR-74 Arginine in the genetic susceptibility to Graves’ disease. Program of the 84th Annual Meeting of the Endocrine Society, San Francisco, Cal., June 19–2–22, 2002, Abstract OR22-5.Google Scholar
  7. 7.
    Marga M., Denisova A., Sochnev A., Pirags V., Farid N.R. Two HLA-DRB1 alleles confer independent genetic susceptibility to Graves’ disease: Relevance of cross-population studies. Am. J. Med. Genet. 2001, 102: 188–191.PubMedCrossRefGoogle Scholar
  8. 8.
    Nelson J.L. Microchimerism: incidental by-product of pregnancy or active participant in human health? Trends Mol. Med. 2002, 8: 109–113.PubMedCrossRefGoogle Scholar
  9. 9.
    Tomer Y., Greenberg D.A., Concepcion E.S., Davies T.F. Genetic studies in a cohort of 102 multiplex autoimmune thyroid disease families with 540 individuals Program of the 84th Annual Meeting of the Endocrine Society, San Francisco, Cal., June 19–22, 2002, Abstract OR22-3Google Scholar
  10. 10.
    Frecker M., Stensky V., Balazs C., Kozma L., Kraszits E., Farid N.R. Genetic factors in Graves’ disease. Clin. Endocrinol. (Oxf.) 1986, 25: 479–484.CrossRefGoogle Scholar
  11. 11.
    Ludgate M., Baker G. Unlocking the immunological mechanisms of orbital inflammation in thyroid eye disease. Clin. Exp. Immunol. 2002, 127: 193–198.PubMedCentralPubMedCrossRefGoogle Scholar
  12. 12.
    Heufelder A.E. Pathogenesis of opthalmopathy in autoimmune thyroid disease. Rev. Endocr. Metab. Disord. 2000, 1: 87–95.PubMedCrossRefGoogle Scholar
  13. 13.
    Valyasevi R.W., Harteneck D.A., Dutton C.M., Bahn R.S. Stimulation of adipogenesis, peroxisome proliferatoractivated receptor-γ (PPARγ) and the thyrotropin receptor by PPARγ agonist in human orbital preadipocyte fibrobasts. J. Clin. Endocrinol. Metab. 2002, 87: 2352–2358.PubMedGoogle Scholar
  14. 14.
    Koumas L., Smith T.J., Phipps R.P. Fibroblast subsets in the human orbit: Thy-1+ and Thy-1- subpopulations exhibit distinct phenotypes. Eur. J. Immunol. 2002, 32: 477–485.PubMedCrossRefGoogle Scholar

Copyright information

© Italian Society of Endocrinology (SIE) 2003

Authors and Affiliations

  1. 1.Osancor Biotech Inc.WatfordUK
  2. 2.Department of EndocrinologyUniversity P. Stradins HospitalRigaLatvia

Personalised recommendations